Clinical Trials Logo
  1. Home
  2. Adverse Drug Events
  3. NCT01091038
  4. Details
NCT01091038 Clinical Trial

Improving Safety by Basic Computerizing Outpatient Prescribing

Adverse Drug Events Clinical Trial

Official title:
Improving Safety by Basic Computerizing Outpatient Prescribing

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT01091038
Other study ID # 0008-44
Secondary ID
Status Completed
Phase Phase 2/Phase 3
First received
Last updated
Start date August 2001
Est. completion date August 2007

Study information
Verified date October 2023
Source Indiana University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study will measure the effect of basic clinical decision support on medical errors and adverse drug events in the ambulatory setting.

Recruitment information / eligibility
Status Completed
Enrollment 228
Est. completion date August 2007
Est. primary completion date August 2007
Accepts healthy volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - provider practicing at sites implementing order entry with basic clinical decision support using either the longitudinal medical record (LMR) or Medical Gopher Exclusion Criteria: - provider or practice unwilling to participate

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Basic Clinical Decision Support
The computerized physician order entry (CPOE) intervention provides physicians with a menu of medications from the formulary, default doses, and a range of potential doses for each medication. Physicians were required to enter dosage, route, and frequency for all orders. Also, CPOE ensured that all orders were legible and included the prescribing physician's signature. For a number of medications, the system displayed relevant laboratory results on the screen at the time of ordering. Other features included consequent orders, which are orders that should follow from other orders, and drug-allergy checking, drug-drug interaction checking, and drug-laboratory checking. This included checking for the most frequent drug allergies, about 80 carefully selected drug-drug interactions, and several drug-laboratory combinations
• Routine Care
Routine Care

Locations
Country Name City State
United States Partner's Healthcare Boston Massachusetts
United States Wishard Helath Services Indianapolis Indiana

Sponsors (2)
Lead Sponsor Collaborator
Indiana University Brigham and Women's Hospital

Country where clinical trial is conducted

United States, 

References & Publications (1)

Hope C, Overhage JM, Seger A, Teal E, Mills V, Fiskio J, Gandhi TK, Bates DW, Murray MD. A tiered approach is more cost effective than traditional pharmacist-based review for classifying computer-detected signals as adverse drug events. J Biomed Inform. 2003 Feb-Apr;36(1-2):92-8. doi: 10.1016/s1532-0464(03)00059-5. — View Citation

Outcome
Type Measure Description Time frame Safety issue
Primary Adverse Drug Events Adverse drug events are measured through use of a computerized surveillance system augmented by focused structured human review 6 months
Primary Medical Errors Medical Errors are identified through a computerized surveillance system with structured human review 6 months
See also
  Status Clinical Trial Phase
Completed NCT02239237 - Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study
Completed NCT01179867 - Using Novel Canadian Resources to Improve Medication Reconciliation at Discharge N/A
Completed NCT02191358 - YouScript IMPACT Registry N/A
Completed NCT02059044 - Information Systems-enabled Outreach Program for Adverse Drug Events N/A
Completed NCT01164137 - Eliminating Risk of Preventable Adverse Drug Events at the Hospital-community Interface of Care N/A
Completed NCT02482025 - The Secure Messaging for Medication Reconciliation Tool (SMMRT) Trial N/A
Completed NCT04692220 - Drug-Related Problems : Focus on Age and Diabetes
Completed NCT02378220 - Pharmacogenetic Testing Among Home Health Patients N/A
Completed NCT01337063 - Multi-Center Medication Reconciliation Quality Improvement Study N/A
Completed NCT02593916 - Response to Medication Registry
Completed NCT00013143 - Patient Profiling and Provider Feedback to Reduce Adverse Drug Events N/A
Withdrawn NCT00606606 - Reducing Adverse Drug Events in the Nursing Home N/A
Completed NCT02805270 - Impact of Medication Reconciliation Intervention on the Rate of Preventable Adverse Drug Events (ADEs) and Healthcare Utilization N/A
Completed NCT02026453 - Pharmacists and Pharmacy Technicians to Improve Admission Medication History Accuracy N/A
Completed NCT01764204 - Hospital Intensive Monitoring of Adverse Drug Reactions of Qingkailing Injection In The Next Two Years N/A
Completed NCT01531088 - Enhancing the Detection and Management of Adverse Drug Events in Nursing Homes N/A
Completed NCT02122965 - The Effect of Medication Review in High-risk Emergency Department Patients N/A
Completed NCT00780572 - Implementation of Real-time ADE Surveillance and Decision Support N/A
Recruiting NCT04479553 - Post-marketing Safety Surveillance of Qizhi Tongluo Capsules:a Registry Study.
Active, not recruiting NCT00740675 - Ambulatory Medication Reconciliation Following Hospital Discharge N/A